Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Diltiazem 0.4% ointment
0107010AAAAAQAQ
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 0.5% ointment
0107010AAAAALAL
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 1% cream
0107010AAAAANAN
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 4% cream
0107010AAAAAFAF
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 4% ointment
0107010AAAAAPAP
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 5% cream
0107010AAAAAMAM
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
|
Diocalm Complete pack
0104020L0BNAAAM
|
Diocalm Complete | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diocalm Dual Action chewable tablets
0104020N0BBAAAC
|
Diocalm (Diarrhoea) | Opium and morphine | Gastro-Intestinal System | No data available |
|
Diocalm Ultra 2mg capsules
0104020L0BEAAAA
|
Diocalm Ultra (Acute Diarrhoea) | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diocaps 2mg capsules
0104020L0BFAAAA
|
Diocaps | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Dioraleze 2mg capsules
0104020L0BUAAAA
|
Dioraleze | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Dipentum 250mg capsules
0105010C0BBAAAA
|
Dipentum | Olsalazine sodium | Gastro-Intestinal System | No data available |
|
Dipentum 500mg tablets
0105010C0BBABAD
|
Dipentum | Olsalazine sodium | Gastro-Intestinal System | No data available |
|
Docusate compound 5ml enema
0106020I0AAAGAG
|
Docusate sodium (Systemic) | Docusate sodium | Gastro-Intestinal System | No data available |
|
Docusol Adult 50mg/5ml oral solution
0106020I0BFAAAI
|
Docusol | Docusate sodium | Gastro-Intestinal System | No data available |
|
Docusol Constipation Relief 50mg/5ml oral solution
0106020I0BFACAI
|
Docusol | Docusate sodium | Gastro-Intestinal System | No data available |
|
Dual Lax Extra Strong tablets
010602000BBBHA0
|
Proprietary compound preparation BNF 0106020 | Other stimulant laxative preparations | Gastro-Intestinal System | No data available |
|
Dulcobalance 10g oral powder sachets
0106040X0BCAAAA
|
Dulcobalance | Macrogol 4000 | Gastro-Intestinal System | No data available |
|
Dulcolax Pico 2.5mg Perles
0106020P0BDABAF
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
Dymotil 2.5mg/25microgram tablets
0104020H0BFAAAA
|
Dymotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | No data available |
|
Dyspamet 200mg chewable tablets
0103010D0BCAAAF
|
Dyspamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Dyspamet 200mg/5ml oral suspension
0103010D0BCABAG
|
Dyspamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Elafibranor 80mg tablets
0109010W0AAAAAA
|
Elafibranor | Elafibranor | Gastro-Intestinal System | No data available |
|
Eluxadoline 75mg tablets
0102000AKAAABAB
|
Eluxadoline | Eluxadoline | Gastro-Intestinal System | No data available |
|
Eno effervescent powder
010102100BBASA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.